Other languages Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

Equities

TKD

JP3463000004

Market Closed - BOERSE MUENCHEN Other stock markets 19:44:00 14/06/2024 BST			5-day change	1st Jan Change
24.48 ^EUR	-0.16%		-1.73%	-5.45%

06-14	Takeda Signs Option Agreement with Ascentage to License Leukemia Drug	MT
06-14	Takeda Pharmaceutical Company Limited Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, Third-Generation BCR-ABL Tyrosine Kinase Inhibitor	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takeda Signs Option Agreement with Ascentage to License Leukemia Drug	06-14
Takeda Pharmaceutical Company Limited Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, Third-Generation BCR-ABL Tyrosine Kinase Inhibitor	06-14
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema	06-06
Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India	06-06
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints	06-03
Takeda Says Narcolepsy Drug Meets Main, Secondary Goals in Trial	06-03
Takeda Pharmaceutical Company Limited to Present Positive Results from its Phase 2B Trial of TAK-861	06-03
GSK blood cancer drug nearly halves risk of death in late-stage trial	06-02
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	06-01
Takeda Pharmaceutical Says Recombinant ADAMTS13 Gets Approval Recommendation From European Medicines Agency's CHPM	05-31
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura	05-31
Pharmakonzern Takeda plant Abbau von bis zu 120 Stellen in Opfikon	05-31
BHP pursuit of Anglo American highlights corporate-led UK M&A upswing	05-30
Evotec steigt aus Gentherapie-Geschäft aus - Ergebniseinbruch zum Jahresstart	05-22
Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment	05-16
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification	05-15
FDA extends review of Ascendis Pharma's hormone disorder therapy	05-14
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute	05-14
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute	05-14
Sector Update: Health Care Stocks Mixed Late Afternoon	05-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

Equities

TKD

JP3463000004

Other languages

Filters